Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes
BACKGROUND Whether there are differences in the risk profile and treatment effect in patients recruited in a low recruitment center (LRC) versus patients recruited in a high recruitment center (HRC) in a randomized multicenter trial remains unknown. METHODS AND RESULTS This study included 4018 patie...
Enregistré dans:
Auteurs principaux: | Gjin Ndrepepa, Franz‐Josef Neumann, Maurizio Menichelli, Isabell Bernlochner, Gert Richardt, Jochen Wöhrle, Bernhard Witzenbichler, Katharina Mayer, Salvatore Cassese, Senta Gewalt, Erion Xhepa, Sebastian Kufner, Hendrik B. Sager, Michael Joner, Tareq Ibrahim, Karl‐Ludwig Laugwitz, Heribert Schunkert, Stefanie Schüpke, Adnan Kastrati |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f2046ed721094811a4bcf71a9a813a01 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
par: Mshelbwala FS, et autres
Publié: (2020) -
Recruitment Practices in Multicenter Randomized Clinical Trials: Time for a Relook
par: Prakriti Gaba, et autres
Publié: (2021) -
Promoting vascular healing using nanofibrous ticagrelor-eluting stents
par: Lee CH, et autres
Publié: (2018) -
Prolonged ventricular pause associated with ticagrelor use: A case report
par: Alaa Rahhal, et autres
Publié: (2021) -
Strategic approach to developing a self-microemulsifying drug delivery system to enhance antiplatelet activity and bioavailability of ticagrelor
par: Na YG, et autres
Publié: (2019)